ConductScience.org, home
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
API referenceFor AI assistants

Trial · NCT00968708

Adverse events1,464

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

621 to 640 of 1,464

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousBronchial hyperreactivityRespiratory, thoracic and mediastinal disordersPlacebo02,679
seriousBronchial hyperreactivityRespiratory, thoracic and mediastinal disordersAlogliptin12,701
seriousBronchospasmRespiratory, thoracic and mediastinal disordersPlacebo12,679
seriousBronchospasmRespiratory, thoracic and mediastinal disordersAlogliptin02,701
seriousBullous lung diseaseRespiratory, thoracic and mediastinal disordersPlacebo02,679
seriousBullous lung diseaseRespiratory, thoracic and mediastinal disordersAlogliptin12,701
seriousChronic respiratory failureRespiratory, thoracic and mediastinal disordersPlacebo12,679
seriousChronic respiratory failureRespiratory, thoracic and mediastinal disordersAlogliptin02,701
seriousCoughRespiratory, thoracic and mediastinal disordersPlacebo02,679
seriousCoughRespiratory, thoracic and mediastinal disordersAlogliptin12,701
seriousHydrothoraxRespiratory, thoracic and mediastinal disordersPlacebo12,679
seriousHydrothoraxRespiratory, thoracic and mediastinal disordersAlogliptin02,701
seriousLaryngeal oedemaRespiratory, thoracic and mediastinal disordersPlacebo02,679
seriousLaryngeal oedemaRespiratory, thoracic and mediastinal disordersAlogliptin12,701
seriousLung disorderRespiratory, thoracic and mediastinal disordersPlacebo12,679
seriousLung disorderRespiratory, thoracic and mediastinal disordersAlogliptin02,701
seriousPickwickian syndromeRespiratory, thoracic and mediastinal disordersPlacebo12,679
seriousPickwickian syndromeRespiratory, thoracic and mediastinal disordersAlogliptin02,701
seriousPleurisyRespiratory, thoracic and mediastinal disordersPlacebo12,679
seriousPleurisyRespiratory, thoracic and mediastinal disordersAlogliptin02,701

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00968708/events?page=32

API referenceFor AI assistants